ACTU – actuate therapeutics, inc. - common stock (US:NASDAQ)
Stock Stats
News
Actuate Announces FDA Rare Pediatric Disease Designation Granted to Elraglusib for Treatment of Ewing Sarcoma
Actuate to Participate in Lantern’s Pharma Webinar on AI-Driven Drug Development
Actuate Announces Scientific Reports Publication on Elraglusib’s Novel Immunomodulatory Mechanism of Action as a GSK-3ß Inhibitor
Actuate Announces Upcoming Presentation on Initial Data on Elraglusib in Combination with FOLFIRINOX at the AACR Special Conference on Advances in Pancreatic Cancer Research
Actuate Receives FDA Orphan Drug Designation for Elraglusib for Treatment of Soft Tissue Sarcomas
Form 10-Q ACTUATE THERAPEUTICS, For: Sep 30
Form 8-K ACTUATE THERAPEUTICS, For: Nov 12
Form 10-Q ACTUATE THERAPEUTICS, For: Jun 30
Form SEC STAFF LETTER ACTUATE THERAPEUTICS,
Form SEC STAFF LETTER ACTUATE THERAPEUTICS,
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.